Medicine & Health

Researchers at Washington University School of Medicine, the Mayo Clinic in Rochester, Minn., and The Neuro of McGill University have received a five-year grant expected to total $35.1 million for an extension of a study designed to develop biomarkers that indicate which people with REM sleep behavior disorder will go on to develop neurodegenerative diseases.

Neuroscientists in Arts & Sciences discovered that the daily release of hormones depends on the coordinated activity of clocks in two parts of the brain, a finding that could have implications for human diseases.

Henry “Roddy” Roediger and James Wertsch, both in Arts & Sciences, will use a grant from the James S. McDonnell Foundation to encourage the interdisciplinary study of collective memory.

A new study into cognitive control from the lab of Todd Braver promises to be the first of many aimed at understanding its origins in the brain and its variations between people and among groups.

New research from physicists in Arts & Sciences reveals that neurons in the visual cortex — the part of the brain that processes visual stimuli — respond differently to the same kind of stimulus over time.

The School of Medicine’s Robyn Klein, MD, PhD, has received an $8.7 million grant from the National Institutes of Health (NIH) to investigate how viruses may cause diseases of “pathological forgetting.”

Research from the lab of Deanna Barch shows a lasting relationship between childhood poverty, brain development.

Researchers at Washington University School of Medicine have identified the brain regions involved in choosing whether to find out if a bad event is about to happen. The findings are published June 11 in Neuron.

Researchers at Washington University School of Medicine have discovered that the immune cells stationed in the protective tissue known as the meninges come primarily from the skull. The finding opens up the possibility of developing therapies to target such cells as a way to prevent or treat brain conditions.

A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration. The system developed by Neurolutions Inc., a WashU startup, relied on innovative multidisciplinary research at the university.